186 related articles for article (PubMed ID: 37435002)
1. The Prognostic Value of TP53 Mutations in Adult Acute Myeloid Leukemia: A Meta-Analysis.
Qin G; Han X
Transfus Med Hemother; 2023 Jun; 50(3):234-244. PubMed ID: 37435002
[TBL] [Abstract][Full Text] [Related]
2. The prognostic impact of tet oncogene family member 2 mutations in patients with acute myeloid leukemia: a systematic-review and meta-analysis.
Wang R; Gao X; Yu L
BMC Cancer; 2019 Apr; 19(1):389. PubMed ID: 31023266
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of IDH2R140 and IDH2R172 mutations in patients with acute myeloid leukemia: a systematic review and meta-analysis.
Qin Y; Shen K; Liu T; Ma H
BMC Cancer; 2023 Jun; 23(1):527. PubMed ID: 37291515
[TBL] [Abstract][Full Text] [Related]
4. Favorable prognosis of biallelic CEBPA gene mutations in acute myeloid leukemia patients: a meta-analysis.
Li HY; Deng DH; Huang Y; Ye FH; Huang LL; Xiao Q; Zhang B; Ye BB; Lai YR; Mo ZN; Liu ZF
Eur J Haematol; 2015 May; 94(5):439-48. PubMed ID: 25227715
[TBL] [Abstract][Full Text] [Related]
5. DNMT3A R882 Mutations Predict a Poor Prognosis in AML: A Meta-Analysis From 4474 Patients.
Yuan XQ; Peng L; Zeng WJ; Jiang BY; Li GC; Chen XP
Medicine (Baltimore); 2016 May; 95(18):e3519. PubMed ID: 27149454
[TBL] [Abstract][Full Text] [Related]
6. Functional Classification of
Dutta S; Pregartner G; Rücker FG; Heitzer E; Zebisch A; Bullinger L; Berghold A; Döhner K; Sill H
Cancers (Basel); 2020 Mar; 12(3):. PubMed ID: 32164171
[TBL] [Abstract][Full Text] [Related]
7. Association between DNMT3A mutations and prognosis of adults with de novo acute myeloid leukemia: a systematic review and meta-analysis.
Tie R; Zhang T; Fu H; Wang L; Wang Y; He Y; Wang B; Zhu N; Fu S; Lai X; Shi J; Huang H
PLoS One; 2014; 9(6):e93353. PubMed ID: 24936645
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of ASXL1 mutations in patients with myelodysplastic syndromes and acute myeloid leukemia: A meta-analysis.
Zhang A; Wang S; Ren Q; Wang Y; Jiang Z
Asia Pac J Clin Oncol; 2023 Oct; 19(5):e183-e194. PubMed ID: 36471477
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of the EVI1 gene expression in patients with acute myeloid leukemia: a meta-analysis.
Wu X; Wang H; Deng J; Zheng X; Ling Y; Gong Y
Ann Hematol; 2019 Nov; 98(11):2485-2496. PubMed ID: 31482295
[TBL] [Abstract][Full Text] [Related]
10. Correlation Between Isocitrate Dehydrogenase Gene Aberrations and Prognosis of Patients with Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis.
Xu Q; Li Y; Lv N; Jing Y; Xu Y; Li Y; Li W; Yao Z; Chen X; Huang S; Wang L; Li Y; Yu L
Clin Cancer Res; 2017 Aug; 23(15):4511-4522. PubMed ID: 28246275
[No Abstract] [Full Text] [Related]
11. Role of ASXL1 and TP53 mutations in the molecular classification and prognosis of acute myeloid leukemias with myelodysplasia-related changes.
Devillier R; Mansat-De Mas V; Gelsi-Boyer V; Demur C; Murati A; Corre J; Prebet T; Bertoli S; Brecqueville M; Arnoulet C; Recher C; Vey N; Mozziconacci MJ; Delabesse E; Birnbaum D
Oncotarget; 2015 Apr; 6(10):8388-96. PubMed ID: 25860933
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of ASXL1 mutations in acute myeloid leukemia: A meta-analysis.
Lipilkin PV; Kulaeva ED; Mashkina EV
Leuk Res; 2022 Sep; 120():106910. PubMed ID: 35785697
[TBL] [Abstract][Full Text] [Related]
13. Independent prognostic significance of TP53 mutations in adult acute myeloid leukaemia with complex karyotype.
Xu N; Lai YY; Chen WM; Jiang H; Wang Y; Wang X; Zhao XS; Huang XJ; Jiang Q; Qin YZ
Int J Lab Hematol; 2022 Oct; 44(5):892-899. PubMed ID: 35505580
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of TP53 concurrent mutations for EGFR- TKIs and ALK-TKIs based targeted therapy in advanced non-small cell lung cancer: a meta-analysis.
Qin K; Hou H; Liang Y; Zhang X
BMC Cancer; 2020 Apr; 20(1):328. PubMed ID: 32299384
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of
Ye W; Ma M; Wu X; Deng J; Liu X; Zheng X; Gong Y
BMJ Open; 2023 Feb; 13(2):e062376. PubMed ID: 36725100
[TBL] [Abstract][Full Text] [Related]
16. Role of CD25 expression on prognosis of acute myeloid leukemia: A literature review and meta-analysis.
Li J; Ran Q; Xu B; Luo X; Song S; Xu D; Zhang X
PLoS One; 2020; 15(7):e0236124. PubMed ID: 32687530
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of CD56 in patients with acute myeloid leukemia: a meta-analysis.
Xu S; Li X; Zhang J; Chen J
J Cancer Res Clin Oncol; 2015 Oct; 141(10):1859-70. PubMed ID: 25924702
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of TP53 gene mutations in myelodysplastic syndromes and acute myeloid leukemia treated with azacitidine.
Bally C; Adès L; Renneville A; Sebert M; Eclache V; Preudhomme C; Mozziconacci MJ; de The H; Lehmann-Che J; Fenaux P
Leuk Res; 2014 Jul; 38(7):751-5. PubMed ID: 24836762
[TBL] [Abstract][Full Text] [Related]
19. The prognostic impact of variant allele frequency (VAF) in TP53 mutant patients with MDS: A systematic review and meta-analysis.
Deng J; Wu X; Ling Y; Liu X; Zheng X; Ye W; Gong Y
Eur J Haematol; 2020 Nov; 105(5):524-539. PubMed ID: 32621334
[TBL] [Abstract][Full Text] [Related]
20. Molecular characterization and prognosis of mutant TP53 acute myeloid leukemia and myelodysplastic syndrome with excess blasts.
Shen K; Hu DY; Zhang ZB; Guo YS; Zhang FH; Chen SN
Int J Lab Hematol; 2023 Jun; 45(3):344-352. PubMed ID: 36860196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]